Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01160588 · ClinicalTrials.gov registry record
Brain Markers of Anxiety Disorders and SSRI/CBT Treatment in Children and Adolescents
A clinical trial, sponsored by University of Michigan.
- Completed
- Registry status
- 156
- Enrollment target
NCT01160588 is a clinical trial that has completed, run by University of Michigan. The registered enrollment target is 156 participants.
The verdict
NCT01160588 has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- 156 participants
- Enrollment target
Study Summary
This study will attempt to identify gene and brain activity markers that predict whether children and adolescents with anxiety disorders will respond to selective serotonin reuptake inhibitor medications or Cognitive Behavioral Therapy (CBT).
Interventions
- DRUG Sertraline
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 156 participants |
| Start Date | 2010-07 |
| Est. Completion | 2015-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01160588
The ClinicalTrials.gov registry entry for NCT01160588 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 156 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Sertraline is the first listed.
NCT01160588 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01160588 about?
NCT01160588 is a clinical study titled "Brain Markers of Anxiety Disorders and SSRI/CBT Treatment in Children and Adolescents". This study will attempt to identify gene and brain activity markers that predict whether children and adolescents with anxiety disorders will respond to selective serotonin reuptake inhibitor medications or Cognitive Behavioral Therapy (CBT).
What is the current status of trial NCT01160588?
This trial is currently completed. The enrollment target is 156 participants. The study started on 2010-07. Estimated completion is 2015-03.
What interventions are being tested in trial NCT01160588?
The interventions under investigation include: Sertraline (DRUG).
Who is sponsoring clinical trial NCT01160588?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.